Literature DB >> 15946230

Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis.

A Eroglu, C Kurtman, A Ulu, R Cam, N Akar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15946230     DOI： 10.1111/j.1538-7836.2005.01346.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis.

Authors:  Aydan Eroglu; Arzu Ulu; Nejat Akar
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

2.  Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.

Authors:  Aydan Eroglu; Arzu Ulu; Ragip Cam; Cengiz Kurtman; Nejat Akar
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

Review 3.  Assessing risk of venous thromboembolism in the patient with cancer.

Authors:  Alok A Khorana; Gregory C Connolly
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

Review 4.  Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants.

Authors:  Waqas Qureshi; Zeeshan Ali; Waseem Amjad; Zaid Alirhayim; Hina Farooq; Shayan Qadir; Fatima Khalid; Mouaz H Al-Mallah
Journal:  Front Cardiovasc Med       Date:  2016-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.